Interestingly, the majority (>55%) of such service providers firms are based in Europe

by Kevin Doe on Aug 23, 2021 Medicine 118 Views

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).


To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this -


The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

§  Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

§  Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

§  Type of Drug Molecule

§  Biologics 

§  Small Molecule

§  Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific


The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech


To Request for sample report -


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Role of Non-Profit / Academic Organizations


6. Company Profiles

7.  Partnerships

8. Big Pharma Initiatives

9. Case Study: Discontinued Drug Development Programs

10. Cost Saving Analysis

11. Market Forecast and Opportunity Analysis

12.  Covid-19 Impact on Drug Repurposing Service Providers Market

13. Recent Advancements and Trends in Outsourcing of Drug Repurposing


14. Interview Transcripts


15. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing


16. Appendix 2: Tabulated Data


17. Appendix 3: List of Companies and Organizations


To purchase a copy, please visit


Other Recent Offerings

1.      Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition), 2021-2030

2.      Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030

3.      Oncolytic Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030


About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at


Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Facebook -

LinkedIn -

Twitter -

Article source:


No comments have been left here yet. Be the first who will do it.

captchaPlease input letters you see on the image.
Click on image to redraw.



Overall Rating:

Most Recent Articles

Latest Comments
on Aug 11, 2022 about zcqsswii asdww
Nice article!! Thanks for sharing this kind of information. I like to share some additional information with your readers.   Is anyone planning to start NFT Marketplacedevelopment?...
on Aug 11, 2022 about Art Design NFT Marketplace
Need help sorting the multiple academic prescriptions of your tutor? Accounting Assignment Help , promptly undertakes all your academic commitments and promises to deliver them on time without...
I hope you post again soon. Big thanks for the useful info.  grocery near me
I want to thank you for sharing such a good information that provides you, that's great. satta king  
on Aug 9, 2022 about DeshawerSatta Result

Translate To: